Consensus on the Treatment of Breast Carcinoma in Elderly Chinese Patients

Elderly(aged ≥ 70 years) patients with breast carcinoma are seldom included in clinical trials. On the other hand, elderly patients are often involved in complicated comorbidities. That gave rise to great controversies over the management of elderly cases with breast carcinoma. Specialists of the breast carcinoma committee of Chinese Geriatric Oncology Society (CGOS) created the principles of reaching consensus on key issues and reserving differences in controversial issues so as to provide evidence-based recommendations for the treatment of breast carcinoma in elderly individuals. The recommendations include local and adjuvant systematic treatments for primary breast carcinoma in elder individuals, neoadjuvant therapy, and treatment approaches for recurrent elderly patients.